DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells
Our findings provide a rationale for the use of targeted NPs as a DNA delivery system for the local expression of therapeutic proteins.
Authors
- Maria Cristina Grimaldi (ORCID: https://orcid.org/0000-0002-4646-0032)
- Michele Dal Bo (ORCID: https://orcid.org/0000-0001-8668-7621)
- Luca De Maso
- Tom Eirik Mollnes (ORCID: https://orcid.org/0000-0002-5785-802X)
- Federico Riccardi (ORCID: https://orcid.org/0009-0005-8534-7795)
- Dick J. Sjöström (ORCID: https://orcid.org/0000-0001-7050-3445)
- Per H. Nilsson (ORCID: https://orcid.org/0000-0002-7192-5794)
- Linnéa Andersson (ORCID: https://orcid.org/0009-0002-0295-2120)
- Paolo Macor (ORCID: https://orcid.org/0000-0003-3079-4019)
- Daniele Sblattero (ORCID: https://orcid.org/0000-0003-4309-242X)
- Sara Bozzer (ORCID: https://orcid.org/0000-0002-0793-0118)
Institutions
- Oslo University Hospital (NO)
- University of Trieste (IT)
- University of Oslo (NO)
- Linnaeus University (SE)
- Nordland Hospital (NO)
- Centro di Riferimento Oncologico (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-22
- DOI
- https://doi.org/10.3389/fimmu.2024.1509322
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Associazione Italiana per la Ricerca sul Cancro